Tuberculosis update: Will good news become bad news?

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 2, 1997, Pages 131-138

  Efferen, Linda S ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LUNG TUBERCULOSIS; REVIEW; UNITED STATES;

HUMANS; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 0031085187     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199703000-00009     Document Type: Article

References (66)

1. Centers for Disease Control: Tuberculosis morbidity: United States, 1995. MMWR CDC Surveill Summ 1996, 45:365-370. An excellent summary of tuberculosis morbidity in the United States for 1995. The accompanying editorial note offers some insights regarding the recent national decrease in tuberculosis morbidity.
2. Moran N: WHO issues another gloomy tuberculosis report. Nat Med 1996, 2:377.
3. Conference Report: The American Lung Association Conference on reestablishing control of tuberculosis in the United States. Am J Respir Crit Care Med 1996, 154:251-262. This paper details the results of a collaborative effort by 66 tuberculosis experts to develop plans to reestablish tuberculosis control in the United States. The recommendations from their deliberations are applicable now and into the 21st century. The key areas dealt with include epidemiology, public health infrastructure, education, research and training, and ethical and legal issues.
4. Calder L, Priest P: One year of tuberculosis in Auckland. N Z Med J 1996, 109:164-167.
5. Evans MR: Is tuberculosis taken seriously in the United Kingdom? BMJ 1995, 311:1483-1485.
6. Leitch AG, Rubilar M, Curnow J, Boyd G, Forbes GI, Burns S, Watt B: Scottish national survey of tuberculosis notifications 1993 with special reference to the prevalence of HIV seropositivity. Thorax 1996, 51:78-81.
7. Casper C, Singh SP, Rane S, Daley CL, Schecter GS, Riley LW, Kreiswirth BN, Small PM: The transcontinental transmission of tuberculosis: a molecular epidemiological assessment. Am J Public Health 1996, 86:551-553.
8. Woelffer GB, Bradford WZ, Paz A, Small PM: A computer-assisted molecular epidemiologic approach to confronting the reemergence of tuberculosis. Am J Med Sci 1996, 311:17-22.
9. Barnes PF, El-Hajj H, Preston-Martin S, Cave MD, Jones BE, Otaya M, Pogoda J, Eisenach KD: Transmission of tuberculosis among the urban homeless. JAMA 1996, 275:305-307.
10. Tamber PS: WHO steps up fight against TB. BMJ 1996, 312:796.
11. Reichman LB: How to ensure the continued resurgence of tuberculosis. Lancet 1996, 347:175-177. A thought-provoking and challenging discussion regarding some of the political and economical barriers to the development of effective global tuberculosis control.
12. Hopewell PC: Mycobacterium tuberculosis: an emerging pathogen? West J Med 1996, 164:33-35. This paper discusses the factors that led to the neglect and subsequent rekindling of interest in tuberculosis and the challenges confronting tuberculosis control efforts both domestically and internationally.
13. Efferen LS, Hyman CL: Tuberculosis reemerges: the captain remains aboard. Curr Opin Pulm Med 1996, 2:236-245.
14. Nightingale SL: From the Food and Drug Administration. JAMA 1996, 275:585.
15. Moore DF, Curry JI: Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR. J Clin Microbiol 1995, 33:2686-2691.
16. Vlaspolder F, Singer P, Roggeveen C: Diagnostic value of an amplification method (Gen-Probe) compared with that of culture for diagnosis of tuberculosis. J Clin Microbiol 1995, 33:2699-2703.
17. Carpentier E, Drouillard B, Dailloux M, Moinard D, Vallee E, Dutilh B, Maugein J, Bergogne-Berezin E, Carbonnelle B: Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study. J Clin Microbiol 1995, 33:3106-3110.
18. Chan CM, Yuen KY, Chan KS, Yam WC, Yim KHM, Ng WF, Ng MH: Single-tube nested PCR in the diagnosis of tuberculosis. J Clin Pathol 1996, 49:290-294.
19. Noordhoek GT, Kaan JA, Mulder S, Wilke H, Kolk AHJ: Routine application of the polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples. J Clin Pathol 1995, 48:810-814.
20. Göçmen A, Kiper N, Ertan Ü, Kalayci Ö, Özçelik U: Is the BCG test of diagnostic value in tuberculosis? Tuber Lung Dis 1994, 75:54-57.
21. Simonney N, Molina JM, Molimard M, Oksenhendler E, Perronne C, Lagrange PH: Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients. Eur J Clin Microbiol Infect Dis 1995, 14:883-891.
22. Rovatti E, Corradi MP, Amicosante M, Tartoni PL, Panini W, Ancora A, Cenci AM, Zucchi L, Monno L, Angarano G, Saltini C: Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection. Eur Respir J 1996, 9:288-292.
23. Houston S, Fanning A: Current and potential treatment of tuberculosis. Drugs 1994, 48:689-708.
24. American Thoracic Society, Centers for Disease Control: Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994, 149:1359-1374.
25. Collazos J, Mayo J, Martinez E: The chemotherapy of tuberculosis from the past to the future. Respir Med 1995, 89:463-469. A good review of current chemotherapeutic options and potential future therapeutic strategies for the treatment of tuberculosis.
26. Hong YP, Kwon DW, Kim SJ, Chang SC, Kang MK, Lee EP, Moon HD, Lew WJ: Survey of knowledge, attitudes and practices for tuberculosis among general practitioners. Tuber Lung Dis 1995, 76:431-435. A survey of general practitioners in Korea demonstrated numerous problems in knowledge, attitudes, and practices regarding tuberculosis. Most alarmingly, 89% of patients were prescribed nonrecommended or unacceptably bad treatment regimens.
27. Yuan L, Richardson E, Kendall PRW: Evaluation of a tuberculosis screening program for high-risk students in Toronto schools. Can Med Assoc J 1995, 153:925-932.
28. DeCock KM: Tuberculosis control in resource-poor settings with high rates of HIV infection [editorial]. Am J Public Health 1996, 86:1071-1073. An editorial comment that highlights practical management strategies for tuberculosis in endemic regions with severely limited resources. These strategies represent a significant contrast to methods used in industrialized nations dealing with significantly lower case rates with "high-tech" strategies for diagnosis and control.
29. Wilkinson D, Davies GR, Connolly C: Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994. Am J Public Health 1996, 86:1094-1097.
30. El-Sadr W, Medard F, Barthaud V: Directly observed therapy for tuberculosis: The Harlem Hospital experience, 1993. Am J Public Health 1996, 86:1146-1149.
31. Morse DI: Directly observed therapy for tuberculosis: spend now or pay later. BMJ 1996, 312:719-720.
32. Rouse DA, Li Z, Bai G-H, Morris SL: Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1995, 39:2472-2477.
33. Scorpio A, Zhang Y: Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 1996, 2:662-667.
34. Bates JH: Tuberculosis chemotherapy: the need for new antituberculosis drugs is urgent Am J Respir Crit Care Med 1995, 151:942-943.
35. Lanckriet C, Lévy-Bruhl D, Bingono E, Siopathis RM: Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Int J Epidemiol 1995, 24:1042-1049.
36. Watson JM: BCG: mass or selective vaccination? J Hosp Infect 1995, 30:508-513.
37. Pharoah PD, Watson JM, Sen S: Selective or universal neonatal BCG immunization: what policy for a district with a high incidence of tuberculosis. Public Health 1996, 110:179-183.
38. Centers for Disease Control: The role of BCG vaccine in the prevention and control of tuberculosis in the United States. MMWR CDC Surveill Summ 1996, 45:1-18. This joint statement reviews previous reports regarding efficacy, safety, and impact of BCG vaccines on tuberculin skin testing results and delineates the policy regarding use of BCG in the United States.
39. Mehra V, Gong J, Iyer D, Lin YG, Boylen CT, Bloom BR, Barnes PF: Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis 1996, 174:431-434.
40. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Orme IM, Baldwin S, D'Souza C, et al.: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996, 2:893-898.
41. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF: Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996, 64:1351-1356.
42. Silva CL, Pietro RLR, Januario A, Bonato VLD, Lima VMF, Da Silva MF, Lowrie DB: Protection against tuberculosis by bone marrow cells expressing mycobacterial hsp65. Immunology 1995, 86:519-524.
43. Silva CL, Silva MF, Pietro RCLR, Lowrie DB: Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65. Infect Immun 1996, 64:2400-2407.
44. Singh NB, Srivastava K, Malaviya B, Kandpal H, Srivaslava A, Gupta HP: The 65 kDa protein of Mycobacterium habana and its putative role in immunity against experimental tuberculosis. Immunol Cell Biol 1995, 73:372-376.
45. Mohle-Boetani JC, Miller B, Halpern M, Trivedi A, Lessler J, Solomon SL, Fenstersheib M: School-based screening for tuberculous infection: a cost-benefit analysis. JAMA 1995, 274:613-619.
46. Starke JR: Tuberculosis skin testing: new schools of thought Pediatrics 1996, 98:123-125.
47. Kohn MR, Arden MR, Vasilakis J, Shenker IR: Directly observed preventive therapy: turning the tide against tuberculosis. Arch Pediatr Adolesc Med 1996, 150:727-729. An interesting report that demonstrates the efficacy of directly observed therapy for prophylaxis as well as the need to interpret and implement national guidelines and recommendations within the context of the needs of the community. Specifically, universal screening of school children is not recommended in the United States, but local groups at high risk, if identified, may derive significant benefit.
48. Camins BC, Bock N, Watkins DL, Blumberg HM: Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion. JAMA 1996, 275:1013-1015. This study illustrates the need for and efficacy of a mandatory, comprehensive tuberculin skin-testing program and may serve as a model for other institutions.
49. Cocchiarella LA, Cohen RAC, Conroy L, Wurtz R: Positive tuberculin skin test reactions among house staff at a public hospital in the era of resurgent tuberculosis. Am J Infect Control 1996, 24:7-12.
50. Graham NMH, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D: Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med 1996, 156:889-894.
51. Roche PW, Feng CG, Britton WJ: Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein M PT64. Scand J Immunol 1996, 43:662-670.
52. Roche PW, Winter N, Triccas JA, Feng CG, Britton WJ: Expression of Mycobacterium tuberculosis MPT64 in recombinant Mycobacterium smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immunol 1996, 103:226-232.
53. Bruins J, Gribnau JH, Bwire R: Investigation into typical and atypical tuberculin sensitivity in the Royal Netherlands Army, resulting in a more rational indication for isoniazid prophylaxis. Tuber Lung Dis 1995, 76:540-544.
54. Ballew KA, Becker DM: Tuberculosis screening in adults who have received Bacille Calmette-Guérin vaccine. South Med J 1995, 88:1025-1030.
55. Ildirim I, Hacimustafaoglu M, Ediz B: Correlation of tuberculin induration with the number of Bacillus Calmette-Guérin vaccines. Pediatr Infect Dis J 1995, 14:1060-1063.
56. Robertson JM, Burtt DS, Edmonds KL, Molina PL, Kiefe CI, Ellner JJ: Delayed tuberculin reactivity in persons of Indochinese origin: implications for preventive therapy. Ann Intern Med 1996, 124:779-764. This study details and defines delayed tuberculin reactivity. This phenomenon has significant potential implications for screening programs targeting Indochinese individuals.
57. Rose DN, Schechter CB, Adler JJ: Interpretation of the tuberculin skin test. J Gen Intern Med 1995, 10:635-642. An interesting and informative reinterpretation of the tuberculin skin test, lending support to the validity of this frequently maligned test as an excellent screening method for distinguishing M. tuberculosis-infected from uninfected individuals.
58. Centers for Disease Control: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR Morbid Mortal Wkly Rep 1994, 43:1-132.
59. Zurlo JJ: Tuberculosis control in health care workers: an algorithmic approach. Am J Infect Control 1996, 24:79-82.
60. McDiarmid M, Gamponia MJ, Ryan MAK, Hirshon JM, Gillen NA, Cox M: Tuberculosis in the workplace: OSHA's compliance experience. Infect Control Hosp Epidemiol 1996, 17:159-164.
61. Grimes RM, Grimes DE, Graviss E: Tuberculosis control in health care workers: an algorithmic approach. Am J Infect Control 1996, 24:70-77.
62. Walls C: Implementing tuberculosis control guidelines in a hospital environment. N Z Med J 1996, 109:12-13.
63. Zaza S, Blumberg HM, Beck-Sagué C, Haas WH, Woodley CL, Pineda M, Parrish C, Crawford JT, McGowan JE Jr, Jarvis WR: Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis 1995, 172:1542-1549. An important work that illustrates the impact of tuberculosis as an occupational hazard and health care workers with active tuberculosis as the source of outbreak transmission. The importance of early identification and isolation of tuberculosis patients and adequate tuberculin skin testing programs and treatment for health care workers is delineated.
64. Lai KK, Fontecchio SA, Kelley AL, Melvin ZS: Knowledge of the transmission of tuberculosis and infection control measures for tuberculosis among healthcare workers. Infect Control Hosp Epidemiol 1996, 17:168-170. This report highlights the need for health care workers to be reeducated about tuberculosis.
65. Wallace D: The resurgence of tuberculosis. Lancet 1996, 347:1115-1116.
66. Frieden TR: Clarifying the issues in tuberculosis control. Am J Public Health 1996, 86:267-268.